Home Consumer Goods Mannkind announces new product development

Mannkind announces new product development

SHARE

Hakan Edstrom, the president, CEO and director of MannKind Corp., a biotech company based in Danbury, this morning announced that the development of pulmonary hypertension and pain management drugs is underway. In the earnings portion of this morning’s conference call, Pfeffer said operating, administrative and research and development expenses have all decreased. The net loss…

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email